Occurrence of malignant neoplasia in patients with primary hyperparathyroidism

Research output: Contribution to journalArticle

3 Citations (Scopus)

Abstract

Introduction: The association between primary hyperparathyroidism (1HPT) and cancer is debated. The present study was aimed to investigate the occurrence of neoplasia in 1HPT. Patients and methods: All consecutive patients (n = 1750) referred to our "Osteoporosis and Metabolic Disease" outpatients clinic for osteoporosis or hypercalcemia were eligible for the study. The exclusion criteria were: the finding of osteoporosis and/or altered calcium-phosphorous metabolism in the context of investigations for malignancy, the presence of diseases known to influence the cancer risk and the heavy smoking habit. Eventually, 1606 patients (1407 females, 199 males) were enrolled. In all patients calcium-phosphorous metabolism, PTH and vitamin D levels were measured and the occurrence of cancer during the 10. years prior the study inclusion was recorded. Results: One-hundred-sixty-three patients had 1HPT while 1443 had not. Patients with and without 1HPT were comparable for age and gender. In 1HPT patients the occurrence of all, breast, kidney and skin cancer was significantly higher (21.5%, 12.2%, 2.5%, 1.8%, respectively) than in patients without 1HPT (12.4%, 6.9%, 0.3%, 0.3%, p. <. 0.05 for all comparisons). The 1HPT presence was significantly associated with the occurrence of all neoplasia and of breast, skin and kidney neoplasia (odds ratio, 95% confidence interval, p value: 1.93, 1.27-2.92, 0.002; 1.93, 1.11-3.35, 0.002; 9.18, 2.16-38.8, 0.003; 8.23, 1.71-39.5, 0.008, respectively), after adjusting for age, gender (as appropriate), smoking habit and vitamin D levels. Conclusion: During the 10. years prior the diagnosis of 1HPT, the occurrence of all, breast, skin and kidney neoplasia is increased.

Original languageEnglish
Pages (from-to)77-82
JournalEuropean Journal of Internal Medicine
Volume43
DOIs
Publication statusPublished - 2017

Fingerprint

Primary Hyperparathyroidism
Neoplasms
Osteoporosis
Vitamin D
Habits
Breast
Smoking
Calcium
Kidney
Skin
Kidney Neoplasms
Metabolic Diseases
Hypercalcemia
Skin Neoplasms
Ambulatory Care Facilities
Odds Ratio
Confidence Intervals
Breast Neoplasms

Keywords

  • Breast cancer
  • Malignancy
  • Primary hyperparathyroidism
  • Vitamin D

ASJC Scopus subject areas

  • Internal Medicine

Cite this

@article{79cd79f3eb7647348312c2c95f71a80b,
title = "Occurrence of malignant neoplasia in patients with primary hyperparathyroidism",
abstract = "Introduction: The association between primary hyperparathyroidism (1HPT) and cancer is debated. The present study was aimed to investigate the occurrence of neoplasia in 1HPT. Patients and methods: All consecutive patients (n = 1750) referred to our {"}Osteoporosis and Metabolic Disease{"} outpatients clinic for osteoporosis or hypercalcemia were eligible for the study. The exclusion criteria were: the finding of osteoporosis and/or altered calcium-phosphorous metabolism in the context of investigations for malignancy, the presence of diseases known to influence the cancer risk and the heavy smoking habit. Eventually, 1606 patients (1407 females, 199 males) were enrolled. In all patients calcium-phosphorous metabolism, PTH and vitamin D levels were measured and the occurrence of cancer during the 10. years prior the study inclusion was recorded. Results: One-hundred-sixty-three patients had 1HPT while 1443 had not. Patients with and without 1HPT were comparable for age and gender. In 1HPT patients the occurrence of all, breast, kidney and skin cancer was significantly higher (21.5{\%}, 12.2{\%}, 2.5{\%}, 1.8{\%}, respectively) than in patients without 1HPT (12.4{\%}, 6.9{\%}, 0.3{\%}, 0.3{\%}, p. <. 0.05 for all comparisons). The 1HPT presence was significantly associated with the occurrence of all neoplasia and of breast, skin and kidney neoplasia (odds ratio, 95{\%} confidence interval, p value: 1.93, 1.27-2.92, 0.002; 1.93, 1.11-3.35, 0.002; 9.18, 2.16-38.8, 0.003; 8.23, 1.71-39.5, 0.008, respectively), after adjusting for age, gender (as appropriate), smoking habit and vitamin D levels. Conclusion: During the 10. years prior the diagnosis of 1HPT, the occurrence of all, breast, skin and kidney neoplasia is increased.",
keywords = "Breast cancer, Malignancy, Primary hyperparathyroidism, Vitamin D",
author = "Serena Palmieri and Letizia Roggero and Elisa Cairoli and Valentina Morelli and Alfredo Scillitani and Iacopo Chiodini and Cristina Eller-Vainicher",
year = "2017",
doi = "10.1016/j.ejim.2017.06.001",
language = "English",
volume = "43",
pages = "77--82",
journal = "European Journal of Internal Medicine",
issn = "0953-6205",
publisher = "Elsevier B.V.",

}

TY - JOUR

T1 - Occurrence of malignant neoplasia in patients with primary hyperparathyroidism

AU - Palmieri, Serena

AU - Roggero, Letizia

AU - Cairoli, Elisa

AU - Morelli, Valentina

AU - Scillitani, Alfredo

AU - Chiodini, Iacopo

AU - Eller-Vainicher, Cristina

PY - 2017

Y1 - 2017

N2 - Introduction: The association between primary hyperparathyroidism (1HPT) and cancer is debated. The present study was aimed to investigate the occurrence of neoplasia in 1HPT. Patients and methods: All consecutive patients (n = 1750) referred to our "Osteoporosis and Metabolic Disease" outpatients clinic for osteoporosis or hypercalcemia were eligible for the study. The exclusion criteria were: the finding of osteoporosis and/or altered calcium-phosphorous metabolism in the context of investigations for malignancy, the presence of diseases known to influence the cancer risk and the heavy smoking habit. Eventually, 1606 patients (1407 females, 199 males) were enrolled. In all patients calcium-phosphorous metabolism, PTH and vitamin D levels were measured and the occurrence of cancer during the 10. years prior the study inclusion was recorded. Results: One-hundred-sixty-three patients had 1HPT while 1443 had not. Patients with and without 1HPT were comparable for age and gender. In 1HPT patients the occurrence of all, breast, kidney and skin cancer was significantly higher (21.5%, 12.2%, 2.5%, 1.8%, respectively) than in patients without 1HPT (12.4%, 6.9%, 0.3%, 0.3%, p. <. 0.05 for all comparisons). The 1HPT presence was significantly associated with the occurrence of all neoplasia and of breast, skin and kidney neoplasia (odds ratio, 95% confidence interval, p value: 1.93, 1.27-2.92, 0.002; 1.93, 1.11-3.35, 0.002; 9.18, 2.16-38.8, 0.003; 8.23, 1.71-39.5, 0.008, respectively), after adjusting for age, gender (as appropriate), smoking habit and vitamin D levels. Conclusion: During the 10. years prior the diagnosis of 1HPT, the occurrence of all, breast, skin and kidney neoplasia is increased.

AB - Introduction: The association between primary hyperparathyroidism (1HPT) and cancer is debated. The present study was aimed to investigate the occurrence of neoplasia in 1HPT. Patients and methods: All consecutive patients (n = 1750) referred to our "Osteoporosis and Metabolic Disease" outpatients clinic for osteoporosis or hypercalcemia were eligible for the study. The exclusion criteria were: the finding of osteoporosis and/or altered calcium-phosphorous metabolism in the context of investigations for malignancy, the presence of diseases known to influence the cancer risk and the heavy smoking habit. Eventually, 1606 patients (1407 females, 199 males) were enrolled. In all patients calcium-phosphorous metabolism, PTH and vitamin D levels were measured and the occurrence of cancer during the 10. years prior the study inclusion was recorded. Results: One-hundred-sixty-three patients had 1HPT while 1443 had not. Patients with and without 1HPT were comparable for age and gender. In 1HPT patients the occurrence of all, breast, kidney and skin cancer was significantly higher (21.5%, 12.2%, 2.5%, 1.8%, respectively) than in patients without 1HPT (12.4%, 6.9%, 0.3%, 0.3%, p. <. 0.05 for all comparisons). The 1HPT presence was significantly associated with the occurrence of all neoplasia and of breast, skin and kidney neoplasia (odds ratio, 95% confidence interval, p value: 1.93, 1.27-2.92, 0.002; 1.93, 1.11-3.35, 0.002; 9.18, 2.16-38.8, 0.003; 8.23, 1.71-39.5, 0.008, respectively), after adjusting for age, gender (as appropriate), smoking habit and vitamin D levels. Conclusion: During the 10. years prior the diagnosis of 1HPT, the occurrence of all, breast, skin and kidney neoplasia is increased.

KW - Breast cancer

KW - Malignancy

KW - Primary hyperparathyroidism

KW - Vitamin D

UR - http://www.scopus.com/inward/record.url?scp=85020235075&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85020235075&partnerID=8YFLogxK

U2 - 10.1016/j.ejim.2017.06.001

DO - 10.1016/j.ejim.2017.06.001

M3 - Article

AN - SCOPUS:85020235075

VL - 43

SP - 77

EP - 82

JO - European Journal of Internal Medicine

JF - European Journal of Internal Medicine

SN - 0953-6205

ER -